- Open Access
The relationship between regional abdominal fat distribution and both insulin resistance and subclinical chronic inflammation in non-diabetic adults
© Hsieh et al.; licensee BioMed Central Ltd. 2014
- Received: 23 July 2013
- Accepted: 19 March 2014
- Published: 1 April 2014
Obesity is associated with a high risk of insulin resistance (IR) and its metabolic complications. It is still debated that distributions of adipose tissue relate to an excess risk of IR and chronic inflammation in different race. This study was designed to examine the relation between insulin sensitivity, chronic inflammation and central fat distribution in non-diabetic volunteers in Taiwanese.
There were 328 volunteers without family history of diabetes mellitus and with normal oral glucose tolerance test enrolled. Total body fat and abdominal fat were measured. Abdominal fat was categorized into intraperitoneal (IP), retroperitoneal (RP) and subcutaneous (SC) fat. The IR index was estimated by homeostatic model assessment. Five inflammatory markers: adiponectin, leptin, tumor necrosing factor-α (TNF-α), resistin and high sensitive CRP (hs-CRP) were measured.
IR was related to IP fat (r = 0.23, p < 0.001), but not RP fat, SC fat or total body fat. After correcting for age and sex, IP fat was the only significant predictor of IR (r2 = 58%, p = 0.001). Leptin showed the strongest relationship with all fat compartments (IP fat: r = 0.44, p = 0.001; RP fat: r = 0.36, p = 0.005, SC fat: r = 0.54, p < 0.001; total body fat: r = 0.61, p < 0.001). The hs-CRP and adiponectin were closely related both to IP (r = 0.29, p = 0.004; r = -0.20, p = 0.046, respectively) and total body fat (r = 0.29, p = 0.004; r = -0.29, p = 0.005, respectively), but not RP, or SC fat. TNF-α and resistin were not correlated to any fat compartment. After correcting for age and sex, leptin variance was mostly explained by SC fat (41.3%), followed by IP fat (33.6%) and RP fat (25.3%). The hs-CRP and adiponectin variance were mostly explained by IP fat (40% and 49% respectively).
IP fat is better predictors of IR and subclinical chronic inflammation in Taiwanese adults. A disproportionate accumulation of abdominal fat is associated with increased risk of cardiovascular diseases.
- Subcutaneous fat
- Intra-peritoneal fat
- Retroperitoneal fat
- Insulin resistance
- High sensitive C-reactive protein
The prevalence of obesity and overweight are still increasing globally. Compared to other countries of Asian, Taiwan has a higher percentage of people who are obese than Australia, Germany, New Zealand and the UK. In 2005, the prevalence of obesity and overweight in Taiwan are 19.2% and 30.5% in men, 13.4% and 21.3% in women. Central obesity, as waist circumference, is clearly related to high risk of insulin resistance and the associated metabolic complications. From most studies, a more abdominal distribution of fat is associated with type 2 diabetes mellitus and worse outcome of cardiovascular disease. The abdominal fat includes subcutaneous (SC) fat of abdomen, intraperidonial (IP) fat and retroperidonial (RP) fat. However, most studies revealed the metabolic complication with visceral fat and SC fat of abdomen[3, 4]. There are few studies clearly investigate the relationship of metabolic complication with these three reginal fat distribution and separate viseral fat to IP fat and RP fat, eapecially in Asian. How adipose tissue causes metabolic abnormality is often linked with adipokines and other inflammation markers[5, 6]. The most well studied adipokines are leptin and adiponectin. Resistin and TNF-α secreted by adipose tissue may also play roles on regulate insulin resistance. However, how the regional distribution of abdominal adipose tissue affects this adipokines is still controversial in different race. Most studies verified visceral area fat (also known as intra-abdominal fat) is strongly associated with insulin resistance but seldom analyze the fat distribution in the abdomen. Presence of brown adipose tissue, a metabolically highly active organ with increased thermogenic activity, in RP fat is always neglected. As for subcutaneous fat, the correlation to insulin resistance is still debated[8–11]. These inconsistent results are likely because of marked differences in ethnicity of the cohorts studied.
On account of different ethnicity may have different distribution of abdominal fat, in this study, we investigate regional fat deposition of abdomen, homeostatic model assessment for insulin resistance (HOMA-IR) and chronic inflammation factors in healthy non-diabetic Taiwanese adults with large population. The relationship between regional fat deposition and both insulin resistance and chronic inflammation are analyzed. This study was designed to examine the relation between insulin sensitivity, chronic inflammation and central fat distribution in non-diabetic volunteers in Taiwanese.
There were 328 volunteers enrolled to participate in the study. They all had normal blood glucose (179 women and 149 men aged 41 to 59 years; mean ± SD, 49.2 ± 9.0 years) defined by fasting blood glucose less than 100 mg/dL and normal oral glucose tolerance test. Subjects included in this study were all over 40 years old, ethnically Chinese, and from the same region in Taiwan at the time of study. The exclusion criteria were diabetes, hypertension, chronic alcohol drinking and family history with diabetes mellitus, determined by taking a history. Four measurements were taken of all subjects after fasting for more than 8 hours (fasting blood glucose and insulin levels, total body fat, and abdominal fat measurement). Five inflammatory markers: adiponectin, leptin, tumor necrosing factor-α (TNF-α), resistin and high sensitive CRP (hs-CRP) were also measured. The Medical Ethics and Human Clinical Trial Committee of Chang Gung Memorial Hospital approved the study, and all subjects provided written informed consent before participating.
The plasma concentrations of glucose (Hitachi 7250 Special auto-analyzer; Hitachi, Tokyo, Japan) and insulin (Access automated immunoassay; Beckman Instruments, Fullerton, CA) were measured. Insulin resistance (IR) was determined by homeostasis model assessment (HOMA) and calculated using fasting plasma glucose and fasting insulin levels in each participant, as follows: HOMA IR = fasting glucose (mmol/l) × fasting insulin (mU/ml)/22.5.
Inflammatory markers: adiponectin, TNF-α, and resistin were checked with commercially available ELISA kits (R&D Systems Inc). The lower limit of fasting adiponectin detection with this assay was 0.89 ng/ml. The intra-assay coefficients of variation were 2.5, 3.4, and 4.7% at low (19.8 ng/ml), median (69.9 ng/ml) and high (143 ng/ml) levels, respectively. The inter-assay coefficients of variation were 6.8, 5.8 and 6.9% at low (20.5 ng/ml), median (74.4 ng/ml) and high (157 ng/ml) levels. The lower limit of resistin concentration detection with this assay was 0.055 ng/ml. The intra-assay coefficients of variation were 5.0, 5.3, and 3.8% at low (0.60 ng/ml), median (2.26 ng/ml) and high (4.72 ng/ml) levels. Inter-assay coefficients of variation were 8.2, 9.2 and 7.8% at low (0.61 ng/ml), median (2.28 ng/ml) and high (4.72 ng/ml) levels. The lower limit of TNF-αconcentration detection with this assay was 0.5-5.5 pg/ml. The intra-assay coefficients of variation were 5.2, 4.2, and 4.6% at low (48.1 pg/ml), median (317 pg/ml) and high (587 pg/ml) levels. The inter-assay coefficients of variation were 7.4, 4.6 and 5.4% at low (45.8 pg/ml), median (301 pg/ml) and high (587 pg/ml) levels, respectively.
The serum hs-CRP level was measured using a high-sensitivity% monoclonal antibody assay (Diagnostic Systems Laboratories, Inc). The run-to-run CVs, at hs-CRP concentrations of 19.6, 182.9, and 300.4 ng/ml were 3.6, 3.9, and 2.1%.
Leptin was determined by radioimmunoassay (Human Leptin RIA kit, Linco Research, MO, USA). Intra-assay coefficients of variation were 8.3, 3.9, and 3.4% at low (4.9 ng/ml), median (10.4 ng/ml) and high (25.6 ng/ml) levels. The inter-assay coefficients of variation were 6.2, 4.7 and 3.6% at low (4.9 ng/ml), median (10.4 ng/ml) and high (25.6 ng/ml) levels. Analytical sensitivity remained at a level of around 0.5 ng/ml.
All statistical analyses were performed using the Statistical Package for Social Science program (SPSS for Windows, version 11.5; SPSS, Chicago, IL). Continuous variables were expressed as means ± SD. The relationships in variable pairs were analyzed by Person correlation coefficients and stepwise multiple regression analyses. The level of significance was taken as P = less than 0.05.
The characteristics of the study group
Body fat (%)
Intra-peritoneal fat (cm3)
Retro-peritoneal fat (cm3)
Subcutaneous fat (cm3)
Relation between fat compartments and insulin resistance
Relations between fat compartment and chronic inflammation markers after correct for age and sex
Correlation between fat distribution and chronic inflammatory markers (correcting for age and sex)
Intra-peritoneal fat (cm3)
Retro-peritoneal fat (cm3)
Subcutaneous fat (cm3)
Total body fat (cm3)
r = 0.29, p = 0.004
r = 0.20, p = 0.084
r = 0.13, p = 0.216
r = 0.29, p = 0.004
r = -0.20, p = 0.046
r = -0.13, p = 0.222
r = 0.19, p = 0.335
r = -0.29, p = 0.005
r = 0.44, p < 0.001
r = 0.36, p = 0.005
r = 0.54, p < 0.001
r = 0.61, p < 0.001
r = 0.05, p = 0.666
r = -0.36, p = 0.171
r = 0.08, p = 0.886
r = -0.08, p = 0.403
r = 0.08, p = 0.427
r = 0.03, p = 0.740
r = 0.05, p = 0.654
r = 0.03, p = 0.806
r = 0.23, p < 0.001
r = 0.02, p = 0.729
r = 0.05, p = 0.270
r = 0.18, p = 0.075
Leptin showed the strongest relationship with all fat compartments (IP fat: r = 0.44, p = 0.001; RP fat: r = 0.36, p = 0.005, SC fat: r = 0.54, p < 0.001; total body fat: r = 0.61, p < 0.001, Table 2). In a stepwise regression analysis, SC fat explained 41.3% of the variance of leptin levels, IP fat explained 33.6%, and the RP fat explained 25.3%.
Adiponectin was closely related to IP fat (r = -0.20, p = 0.046) and total body fat (r = -0.29, p = 0.005), but not to the SC and RP fat (r = 0.19, p = 0.335; r = -0.13, p = 0.222, respectively, Table 2). In a stepwise regression analysis, the IP fat explained 49% of the variance of adiponectin levels.
TNF-α and resistin were not correlated to all fat compartment.
In this study, we found the relationship between regional abdominal adiposity and insulin resistance in a group of non-diabetic, middle-aged Taiwanese with varying degrees of body mass index. IP fat mass is the best predictor of insulin resistance. In our study, we used CT for adipose tissue evaluation and also for multiple compartments of body measurement. A strong relationship was noted between IP fat and insulin resistance.
In clinical practice, waist circumference as central obesity was used and correlated waist circumference with metabolic syndrome. However, waist circumference is composed of abdominal SC fat, and intra-abdominal fat. Intra-abdominal adipose tissue (visceral fat) is further separated to IP fat and RP fat, a distinction which has been validated in human cadavers. Previous work had verified that most of the intra-abdominal adipose tissue mass is IP (61–71%) and a much smaller element is RP (29–33%). Marin et al’s study has shown IP fat, rather than RP or SC fat, more strongly correlated with systemic metabolic variables (e.g., plasma insulin, blood glucose levels, glucose disposal rate, and systolic blood pressure). There is a higher turnover of lipids in visceral than in the other fat depots, which is closely correlated to systemic insulin resistance and glucose metabolism. However in the study of Abate et al., subcutaneous truncal fat plays a major role in obesity-related insulin resistance in men, whereas IP fat and RP fat have a lesser role. In this study only 39 healthy men were included. The discrepancy may be due to different body fat distribution in different gender, age and ethnicity. For example, multiple insulin resistance risk factors occur in apparently healthy Asian Indians with normal body mass index (BMI)[16–18]. Altered body composition with greater abdominal fat is associated with insulin resistance, hyperinsulinemia, and dyslipidemia in this population. When BMI and body fat (BF%) were studied in Taiwan, Taiwanese subjects had a relatively lower BMI but a higher BF% than Caucasians. In general, the newly proposed Asia-Pacific BMI cutoffs for overweight (> or =23 kg/m2) and obesity (> or =25 kg/m2) may be acceptable to both male and female Taiwanese subjects. The corresponding BF% cutoffs for obesity would be 25% in male and 38% in female Taiwanese subjects, respectively. In our study, we found that IP fat compartment was the only fat compartment that significantly correlated to HOMA IR. SC fat, which is controversial in previous studies, is not an independent factor of insulin resistance in our studies. This allows us to specifically determine which compartment of fat is of primary importance in the etiology of insulin resistance in Taiwanese people.
Many recent studies revealed that chronic inflammation participates in the development of metabolic syndrome related coronary artery disease. These prospective studies also showed an association between central obesity (by waist circumference) and chronic inflammation[20–22]. The hs-CRP value can also be used as an independent predictor of coronary heart disease. The American Heart Association identified this marker as the best clinical detector for cardiovascular disease. Published data also show that visceral adipose tissue is strongly associated with circulating levels of CRP[5, 24, 25]. In our study, the hs-CRP is highly related to IP fat and total body adipose tissue but not RP and SC fat. Here, we further specified that IP fat appears to be the strongest predictor for high hs-CRP.
Leptin, TNF-α, resistin and adiponectin are adipose tissue secretary proteins. Leptin, TNF-α, and resistin correlating with body fat mass, has been reported to be associated with insulin resistance and atherosclerosis[26, 27]. On the other hand, adiponectin has antidiabetic and antiatherogenic properties. Our previous work has confirmed that during weight reduction programs adiponectin plasma levels increase while leptin levels decrease. Leptin levels were thought correlated with total and subcutaneous adipose tissue, but not with visceral adipose tissue[16, 30]. However, in one study investigating South Asian in American, leptin is strongly correlated with both SC fat and visceral fat. In this Taiwanese group, our data clearly show that plasma leptin is associated with all part of adipose tissue, but still the primary relationship is with subcutaneous fat. Therefore, for Taiwanese or Asian, leptin may not be the best predictor for metabolic syndrome, only for general obesity alone. As for adiponectin, our study showed adiponectin level was inversely related to IP fat, but not associated with the SC and RP fat. This result is similar to two studies in different ethnicity[32, 33]. We separated intra-abdominal fat (visceral fat) to intra-pertonium and retro-peritonium, which revealed adiponectin more related to IP fat than fat mass of other area and may be the negative predictor for metabolic syndrome.
TNF-α is an adipokine involved in systemic inflammation and is a member of a group of cytokines that stimulate the acute phase reaction. However, obesity, especially IP fat accumulation needs long-term changes. Although previous study revealed that TNF-α increases leptin gene expression and circulating leptin levels, some data revealed no correlation found between TNF-α with any fat distribution[5, 35]. In Beasley et al’ study, this large across racial study demonstrates visceral fat is only positively associated with TNF-α except in black men but not white men. These different results may indicate ethnicity is important in characteristic of fat compartment again. Resistin, a cysteine-rich 12.5 kDa adipocytokine with a controversial history regarding its role in the pathogenesis of obesity-mediated insulin resistance and type 2 diabetes mellitus in rodent models, is still controversial in the role of glucose metabolism in human, is probably involved in the regulation of inflammatory processes rather than in insulin sensitivity[34, 37]. No relationship between fat distribution and resistin is also found in our study. In our results, the amount of IP fat was significantly positive correlated with hs-CRP and leptin but negative correlated with adiponectin. IP fat may be inherently different from RP and SC fat, e.g., in cellular composition, tissue dynamics, adipokine release, and hormonal responses. The “portal theory” also assumes inflammatory factors released from IP fat into the portal vein directly contributes to hepatic insulin resistance.
In conclusion, the findings of this study confirm that IP fat is a strong predictor of insulin resistance and metabolic syndrome in Taiwanese. These observations reinforce the importance of treatment strategies designed to reduce IP part rather than RP part of visceral fat. Our results also suggest a relationship between IP adiposity and the chronic inflammation process. This holds irrespective of age or other potential confounders, and was more prominent than the relationship between total obesity. It may be that, through the inflammation process and adipokines, a disproportionate accumulation of IP fat is associated with increased coronary risk.
This work was supported by research grant (CMRPG8065) from Chang Gung Memorial Hospital - Kaohsiung Medical Center, Chang Gung University College of Medicine, Taiwan.
- Hung KC: Obesity and its related diseases in Taiwan. Obes Rev. 2005, 6: 271-274. 10.1111/j.1467-789X.2005.00175.x.View ArticleGoogle Scholar
- Langenberg C, Sharp SJ, Schulze MB, Rolandsson O, Overvad K, Forouhi NG, Spranger J, Drogan D, Huerta JM, Arriola L, de Lauzon-Guillan B, Tormo MJ, Ardanaz E, Balkau B, Beulens JW, Boeing H, Bueno-de-Mesquita HB, Clavel-Chapelon F, Crowe FL, Franks PW, Gonzalez CA, Grioni S, Halkjaer J, Hallmans G, Kaaks R, Kerrison ND, Key TJ, Khaw KT, Mattiello A, InterAct Consortium: Long-term risk of incident type 2 diabetes and measures of overall and regional obesity: the EPIC-InterAct case-cohort study. PLoS Med. 2012, 9: e1001230-10.1371/journal.pmed.1001230.View ArticlePubMedGoogle Scholar
- Haffner SM: Abdominal adiposity and cardiometabolic risk: do we have all the answer?. Am J Med. 2007, 120 (9 Suppl 1): S10-S16.View ArticlePubMedGoogle Scholar
- Bremer AA, Jialal I: Adipose tissue dysfunction in nascent metabolic syndrome. J Obese. 2013, 2013: 393192-Google Scholar
- Pou KM, Massaro JM, Hoffmann U, Vasan RS, Maurovich-Horvat P, Larson MG, Keaney JF, Meigs JB, Lipinska I, Kathiresan S, Murabito JM, O’Donnell CJ, Benjamin EJ, Fox CS: Visceral and subcutaneous adipose tissue volumes are cross-sectionally related to markers of inflammation and oxidative stress: the Framingham Heart Study. Circulation. 2007, 116: 1234-1241. 10.1161/CIRCULATIONAHA.107.710509.View ArticlePubMedGoogle Scholar
- Tilg H, Moschen AR: Adipocytokines: mediators linking adipose tissue, inflammation and immunity. Nat Rev Immunol. 2006, 6: 772-783. 10.1038/nri1937.View ArticlePubMedGoogle Scholar
- Rabe K, Lehrke M, Parhofer KG, Broedl UC: Adipokines and insulin resistance. Mol Med. 2008, 14: 741-1751.PubMed CentralView ArticlePubMedGoogle Scholar
- Bu J, Feng Q, Ran J, Li Q, Mei G, Zhang Y: Visceral fat mass is always, but adipokines (adiponectin and resistin) are diversely associated with insulin resistance in Chinese type 2 diabetic and normoglycemic subjects. Diabetes Res Clin Pract. 2012, 96: 163-169. 10.1016/j.diabres.2011.12.014.View ArticlePubMedGoogle Scholar
- McLaughlin T, Lamendola C, Liu A, Abbasi F: Preferential fat deposition in subcutaneous versus visceral depots is associated with insulin sensitivity. J Clin Endocrinol Metab. 2011, 96: E1756-E1760. 10.1210/jc.2011-0615.PubMed CentralView ArticlePubMedGoogle Scholar
- Preis SR, Massaro JM, Robins SJ, Hoffmann U, Vasan RS, Irlbeck T, Meigs JB, Sutherland P, D’Agostino RB, O’Donnell CJ, Fox CS: Abdominal subcutaneous and visceral adipose tissue and insulin resistance in the Framingham heart study. Obesity. 2010, 18: 2191-21988. 10.1038/oby.2010.59.PubMed CentralView ArticlePubMedGoogle Scholar
- Usui C, Asaka M, Kawano H, Aoyama T, Ishijima T, Sakamoto S, Higuchi M: Visceral fat is a strong predictor of insulin resistance regardless of cardiorespiratory fitness in non-diabetic people. J Nutr Sci Vitaminol. 2010, 56: 109-116. 10.3177/jnsv.56.109.View ArticlePubMedGoogle Scholar
- Chowdhury B, Sjostrom L, Alpsten M, Kostanty J, Kvist H, Lofgren R: A multicompartment body composition technique based on computerized tomography. Int J Obes Relat Metab Disord. 1994, 18: 219-234.PubMedGoogle Scholar
- Abate N, Burns D, Peshock RM, Garg A, Grundy S: Estimation of adipose tissue mass by magnetic resonance imaging: validation against dissection in human cadavers. J Lipid Res. 1994, 35: 1490-1496.PubMedGoogle Scholar
- Mårin P, Andersson B, Ottosson M, Olbe L, Chowdhury B, Kvist H, Holm G, Sjöström L, Björntorp P: The morphology and metabolism of intraabdominal adipose tissue in men. Metabolism. 1992, 41: 1242-1248. 10.1016/0026-0495(92)90016-4.View ArticlePubMedGoogle Scholar
- Abate N, Garg A, Peshock RM, Stray-Gundersen J, Grundy SM: Relationships of generalized and regional adiposity to insulin sensitivity in men. J Clin Invest. 1995, 96: 88-98. 10.1172/JCI118083.PubMed CentralView ArticlePubMedGoogle Scholar
- Liew CF, Seah ES, Yeo KP, Lee KO, Wise SD: Lean, nondiabetic Asian Indians have decreased insulin sensitivity and insulin clearance, and raised leptin compared to Caucasians and Chinese subjects. Int J Obes Relat Metab Disord. 2003, 27: 784-789. 10.1038/sj.ijo.0802307.View ArticlePubMedGoogle Scholar
- Wulan SN, Westerterp KR, Plasqui G: Ethnic differences in body composition and the associated metabolic profile: a comparative study between Asians and Caucasians. Maturitas. 2010, 65: 315-319. 10.1016/j.maturitas.2009.12.012.View ArticlePubMedGoogle Scholar
- Raji A, Seely EW, Arky RA, Simonson DC: Body fat distribution and insulin resistance in healthy Asian Indians and Caucasians. J Clin Endocrinol Metab. 2001, 86: 5366-5371. 10.1210/jcem.86.11.7992.View ArticlePubMedGoogle Scholar
- Chang CJ, Wu CH, Chang CS, Yao WJ, Yang YC, Wu JS, Lu FH: Low body mass index but high percent body fat in Taiwanese subjects: implications of obesity cutoffs. Int J Obes Relat Metab Disord. 2003, 27: 253-259. 10.1038/sj.ijo.802197.View ArticlePubMedGoogle Scholar
- Festa A, D’Agostino R, Williams K, Karter AJ, Mayer-Davis EJ, Tracy RP, Haffner SM: The relation of body fat mass and distribution to markers of chronic inflammation. Int J Obes Relat Metab Disord. 2001, 25: 1407-1415. 10.1038/sj.ijo.0801792.View ArticlePubMedGoogle Scholar
- Panagiotakos DB, Pitsavos C, Yannakoulia M, Chrysohoou C, Stefanadis C: The implication of obesity and central fat on markers of chronic inflammation: The ATTICA study. Atherosclerosis. 2005, 183: 308-315. 10.1016/j.atherosclerosis.2005.03.010.View ArticlePubMedGoogle Scholar
- Smith J, Al-Amri M, Sniderman A, Cianflone K: Leptin and adiponectin in relation to body fat percentage, waist to hip ratio and the apoB/apoA1 ratio in Asian Indian and Caucasian men and women. Nutr Metab. 2006, 3: 18-10.1186/1743-7075-3-18.View ArticleGoogle Scholar
- Pearson TA, Mensah GA, Alexander RW, Anderson JL, Cannon RO, Criqui M, Fadl YY, Fortmann SP, Hong Y, Myers GL, Rifai N, Smith SC, Taubert K, Tracy RP, Vinicor F, Centers for Disease Control and Prevention; American Heart Association: Markers of inflammation and cardiovascular disease: application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation. 2003, 107: 499-511. 10.1161/01.CIR.0000052939.59093.45.View ArticlePubMedGoogle Scholar
- Forouhi NG, Sattar N, McKeigue PM: Relation of C-reactive protein to body fat distribution and features of the metabolic syndrome in Europeans and South Asians. Int J Obes Relat Metab Disord. 2001, 25: 1327-1331. 10.1038/sj.ijo.0801723.View ArticlePubMedGoogle Scholar
- Lapice E, Maione S, Patti L, Cipriano P, Rivellese AA, Riccardi G, Vaccaro O: Abdominal adiposity is associated with elevated C-reactive protein independent of BMI in healthy nonobese people. Diabetes Care. 2009, 32: 1734-1736. 10.2337/dc09-0176.PubMed CentralView ArticlePubMedGoogle Scholar
- Mattu HS, Randeva HS: Role of adipokines in cardiovascular disease. J Endocrinol. 2013, 216: T17-T36. 10.1530/JOE-12-0232.View ArticlePubMedGoogle Scholar
- Borst SE: The role of TNF-alpha in insulin resistance. Endocrine. 2004, 23: 177-182. 10.1385/ENDO:23:2-3:177.View ArticlePubMedGoogle Scholar
- Hanley AJ, Bowden D, Wagenknecht LE, Balasubramanyam A, Langfeld C, Saad MF, Rotter JI, Guo X, Chen YD, Bryer-Ash M, Norris JM, Haffner SM: Associations of adiponectin with body fat distribution and insulin sensitivity in nondiabetic Hispanics and African-Americans. J Clin Endocrinol Metab. 2007, 92: 2665-2671. 10.1210/jc.2006-2614.View ArticlePubMedGoogle Scholar
- Hsieh CJ, Wang PW: Effectiveness of weight loss in the elderly with type 2 diabetes mellitus. J Endocrinol Invest. 2005, 28: 973-977.View ArticlePubMedGoogle Scholar
- Ramachandran A, Snehalatha C, Vijay V, Satyavani K, Latha E, Haffner SM: Plasma leptin in non-diabetic Asian Indians: association with abdominal adiposity. Diabet Med. 1997, 14: 937-941. 10.1002/(SICI)1096-9136(199711)14:11<937::AID-DIA502>3.0.CO;2-S.View ArticlePubMedGoogle Scholar
- Shah A, Hernandez A, Mathur D, Budoff MJ, Kanaya AM: Adipokines and body fat composition in South Asians: results of the Metabolic Syndrome and Atherosclerosis in South Asians Living in America (MASALA) study. Int J Obes. 2012, 36: 810-816. 10.1038/ijo.2011.167.View ArticleGoogle Scholar
- Indulekha K, Surendar J, Anjana RM, Gokulakrishnan K, Balasubramanyam M, Aravindhan V, Mohan V: Circulating levels of high molecular weight (HMW) adiponectin and total adiponectin in relation to fat distribution, oxidative stress and inflammation in Asian Indians. Dis Markers. 2012, 33: 185-192. 10.1155/2012/672939.PubMed CentralView ArticlePubMedGoogle Scholar
- Kishida K, Kim KK, Funahashi T, Matsuzawa Y, Kang HC, Shimomura I: Relationships between circulating adiponectin levels and fat distribution in obese subjects. J Atheroscler Thromb. 2011, 18: 592-595. 10.5551/jat.7625.View ArticlePubMedGoogle Scholar
- Haluzik M, Haluzikova D: The role of resistin in obesity-induced insulin resistance. Curr Opin Investig Drugs. 2006, 7: 306-311.PubMedGoogle Scholar
- Piche ME, Lemieux S, Weisnagel SJ, Corneau L, Nadeau A, Bergeron J: Relation of high-sensitivity C-reactive protein, interleukin-6, tumor necrosis factor-alpha, and fibrinogen to abdominal adipose tissue, blood pressure, and cholesterol and triglyceride levels in healthy postmenopausal women. Am J Cardiol. 2005, 96: 92-97. 10.1016/j.amjcard.2005.02.051.View ArticlePubMedGoogle Scholar
- Beasley LE1, Koster A, Newman AB, Javaid MK, Ferrucci L, Kritchevsky SB, Kuller LH, Pahor M, Schaap LA, Visser M, Rubin SM, Goodpaster BH, Harris TB: Health ABC study: Inflammation and race and gender differences in computerized tomography-measured adipose depots. Obesity. 2009, 17: 1062-1069. 10.1038/oby.2008.627.PubMed CentralView ArticlePubMedGoogle Scholar
- Pang SS, Le YY: Role of resistin in inflammation and inflammation-related diseases. Cell Mol Immunol. 2006, 3: 29-34.PubMedGoogle Scholar
- Kabir M, Catalano KJ, Ananthnarayan S, Kim SP, Van Citters GW, Dea MK, Bergman RN: Molecular evidence supporting the portal theory: a causative link between visceral adiposity and hepatic insulin resistance. Am J Physiol Endocrinol Metab. 2005, 288: E454-E461. 10.1152/ajpendo.00203.2004.View ArticlePubMedGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited.